Edition:
United States

Intersect ENT Inc (XENT.OQ)

XENT.OQ on NASDAQ Stock Exchange Global Market

33.05USD
4:00pm EDT
Change (% chg)

$-0.65 (-1.93%)
Prev Close
$33.70
Open
$33.50
Day's High
$33.55
Day's Low
$32.85
Volume
55,484
Avg. Vol
65,459
52-wk High
$42.90
52-wk Low
$26.92

Chart for

About

Intersect ENT, Inc. is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. This targeted drug delivery technology... (more)

Overall

Beta: 0.70
Market Cap(Mil.): $1,015.58
Shares Outstanding(Mil.): 30.14
Dividend: --
Yield (%): --

Financials

  XENT.OQ Industry Sector
P/E (TTM): -- 41.63 33.20
EPS (TTM): -0.54 -- --
ROI: -13.75 14.53 13.23
ROE: -13.84 17.68 15.28

BRIEF-Intersect ENT Reports Qtrly Loss Per Share $0.21

* Q1 EARNINGS PER SHARE VIEW $-0.24 -- THOMSON REUTERS I/B/E/S

May 01 2018

BRIEF-Intersect ENT Q4 Revenue $29.5 Million

* INTERSECT ENT REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

Feb 27 2018

Competitors

  Price Chg
Medtronic PLC (MDT.N) $87.73 -0.63

Earnings vs. Estimates